BRIEF published on 09/09/2026 at 13:25, 23 days 7 hours ago BRAIN Biotech AG obtient un paiement d'étape de 11,51 millions d'euros BRAIN Biotech AG Situation Financière Paiement D'étape Deucrictibant Royal Pharma
BRIEF published on 09/09/2026 at 13:25, 23 days 7 hours ago BRAIN Biotech AG Secures EUR 11.51 Million Milestone Payment Financial Position BRAIN Biotech AG Milestone Payment Deucrictibant Royalty Pharma
PRESS RELEASE published on 09/09/2026 at 13:20, 23 days 7 hours ago BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma BRAIN Biotech AG receives EUR 11.51 million milestone payment from Royalty Pharma, enhancing financial position. Expecting additional future milestone payments. CFO sees positive developments Financial Position BRAIN Biotech AG Milestone Payment Royalty Pharma Future Milestones
BRIEF published on 09/09/2026 at 13:17, 23 days 7 hours ago BRAIN Biotech AG obtient 11,51 millions d'euros de Royalty Pharma BRAIN Biotech Impact Financier Paiement D'étape Deucrictibant Royal Pharma
BRIEF published on 09/09/2026 at 13:17, 23 days 7 hours ago BRAIN Biotech AG Secures EUR 11.51 Million from Royalty Pharma Financial Impact BRAIN Biotech Milestone Payment Deucrictibant Royalty Pharma
PRESS RELEASE published on 09/09/2026 at 13:12, 23 days 7 hours ago EQS-Adhoc: BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma BRAIN Biotech AG receives EUR 11.51 million milestone payment from Royalty Pharma for pharma compound development Development BRAIN Biotech AG Milestone Payment Royalty Pharma Pharma Compound
BRIEF published on 08/27/2026 at 07:35, 1 month 6 days ago BRAIN Biotech Reports 9M Results, Targets Break-even EBITDA Financial Results Revenue Forecast Revenue Decline EBITDA Target CEO Commentary
BRIEF published on 08/27/2026 at 07:35, 1 month 6 days ago BRAIN Biotech publie ses résultats des 9 derniers mois et vise un EBITDA à l'équilibre. Résultats Financiers Baisse Des Revenus Prévisions De Revenus Objectif EBITDA Commentaire Du PDG
PRESS RELEASE published on 08/27/2026 at 07:30, 1 month 6 days ago BRAIN Biotech reports its 9M results and continues to target a break-even adjusted Group-EBITDA BRAIN Biotech reports 9M results targeting break-even adjusted Group-EBITDA. BRAINBioIncubator forecast raised, BRAINBiocatalysts lowered. Detailed financial data and outlook included Adjusted EBITDA Financial Forecast Revenue Performance BRAIN Biotech 9M Results
BRIEF published on 07/29/2026 at 14:45, 2 months 4 days ago Dr. Sven K. Weber Appointed CEO of BRAIN Biotech AG CEO Appointment BRAIN Biotech AG Sven K. Weber Adriaan Moelker Enzyme Sector
Published on 10/02/2026 at 13:50, 6 hours 53 minutes ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 7 hours 43 minutes ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 7 hours 43 minutes ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/02/2026 at 13:00, 7 hours 43 minutes ago Datavault AI CEO to Present "Operating System for Tokenized Assets" at XRP Seoul 2026
Published on 10/02/2026 at 20:23, 20 minutes ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 57 minutes ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 1 hour 43 minutes ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 18:00, 2 hours 43 minutes ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 18:00, 2 hours 43 minutes ago AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 2 hours 58 minutes ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 hours 58 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 3 hours 8 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 3 hours 13 minutes ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 3 hours 13 minutes ago Aéroports de Paris SA - Calendrier financier 2027
